News + Publications

April 6, 2017

Growth medium based on human plasma rewires cell metabolism

Cultured human cells are the foundation for disease and drug research. Now Whitehead Institute researchers have designed a growth medium that more closely resembles the cells’ environment in the body—and demonstrated that, relative to decades-old recipes that have remained the workhorses of cell culture studies, it significantly alters the cells’ inner workings.

Whitehead Member David Sabatini

April 4, 2017

Whitehead Member David Sabatini awarded Foundation for the NIH Lurie Prize in Biomedical Sciences

Prize bestowed for discovery of the mTOR pathway’s impact on age-related diseases

Image of an invasive outgrowth of cancer cells

April 3, 2017

Biomarker identified for likely aggressive, early stage breast cancer

Whitehead Institute scientists have identified a gene that could help clinicians discern which patients have aggressive forms of early stage breast cancer, which could prevent hundreds of thousands of women from undergoing unnecessary treatment and save millions of dollars.

Design of red blood cell capable of carrying antigenic peptides

March 6, 2017

Cargo-carrying red blood cells alleviate autoimmune diseases in mice

Using red blood cells modified to carry disease-specific antigens, a team of scientists from Whitehead Institute and Boston Children’s Hospital have prevented and alleviated two autoimmune diseases—multiple sclerosis (MS) and type 1 diabetes—in early stage mouse models.  This research is an exciting step toward therapeutics for autoimmune diseases, which affect an estimated 23 million Americans.

Paradigm Magazine


PDF

Past Issues

2014 Annual Report


PDF

Annual Report Archives

© Whitehead Institute for Biomedical Research              455 Main Street          Cambridge, MA 02142